TTI TETRA TECHNOLOGIES INC
Price Chart
Executive Summary
TETRA Technologies priced a follow-on offering of 10,810,811 shares of common stock at $9.25 per share, raising approximately $94.0 million in net proceeds. The offering represents ~8.0% dilution based on shares outstanding as of March 31, 2026. Proceeds are earmarked for general corporate purposes, including funding a portion of the Arkansas Bromine Project, a $220 million capital project expected to begin operations in early 2028. The offering was priced at an ~10.7% discount to the prior close of $10.36.
Actionable Insight
The dilutive offering at a discount signals near-term selling pressure. Monitor the stock for continued weakness as the 10.8M shares hit the market. The Arkansas Bromine Project narrative provides a long-term catalyst but execution risk is high given the $220M remaining capex and negative free cash flow. Watch for any insider selling after the 60-day lock-up expires.
Key Facts
- Offering of 10,810,811 shares at $9.25 per share, raising ~$94.0 million net proceeds
- Priced at ~10.7% discount to the $10.36 prior close on June 1, 2026
- Dilution of ~8.0% based on 135,296,078 shares outstanding as of March 31, 2026
- Underwriters have a 30-day option for an additional 1,621,621 shares (15% over-allotment)
- Net proceeds to fund general corporate purposes and a portion of the Arkansas Bromine Project
- Arkansas Bromine Project has ~$220 million in remaining capex; plant expected to begin operations in early 2028
- Q1 2026 total revenue of $156.3M was down slightly YoY from $157.1M; Adjusted EBITDA margin fell to 16.4% from 20.4%
- Base business adjusted free cash flow was negative $23.5M in Q1 2026 vs positive $16.2M in Q1 2025
- Lock-up agreements restrict company and insiders from selling shares for 60 days post-offering
Financial Impact
~$94.0 million net proceeds raised; ~8.0% dilution to existing shareholders; offering priced at ~10.7% discount to market
Risk Factors
- Immediate dilution of ~8% from the offering
- Arkansas Bromine Project execution risk with $220M remaining capex and no revenue until early 2028
- Q1 2026 revenue declined YoY and Adjusted EBITDA margin compressed from 20.4% to 16.4%
- Negative base business free cash flow of -$23.5M in Q1 2026 vs +$16.2M in Q1 2025
- Potential for additional equity raises to fund remaining project costs
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-256363 |
| Document: 0001193125-26-256363-index-headers.html | 0001193125-26-256363 |
| Document: 0001193125-26-256363-index.html | 0001193125-26-256363 |
| Document: 0001193125-26-256363.txt | 0001193125-26-256363 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
1d ago
|
424B5
| — | awaiting T+1 | — | — |
|
Jun 2, 2026
3d ago
|
8-K
| $9.74 $9.93 | ▼ −1.95% | ▼ −1.54% | $9.29 (+4.62%) |
|
May 26, 2026
10d ago
|
8-K
| — | awaiting T+1 | — | — |
|
Apr 9, 2026
8w ago
|
DEFA14A
| $8.68 $8.46 | ▼ −2.53% | ▼ −2.47% | $9.29 (+7.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access